Dusquetide for the Treatment of Behcet's Disease

NCT06386744 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Behçet Disease

Interventions

DRUG: Dusquetide

Sponsor

Soligenix